Genito Urinary Translational Study (GUTS) Group
The goal of this forum is to promote the discussion of state-of-the-art research in genito-urinary medicine, with the goal of expanding basic, clinical, and translational research and training at MMC.
Next up on G.U.T.S:
Leif Oxburgh, DVM, PhD
Physiological fibrosis and other strange features of thejuvenile kidney
7 am, Date: January 30, 2014
Dana 9, MMC
Recent Interesting Studies or Reviews:
Combination of Rapamycin, CI-1040, and 17-AAG Inhibits Metastatic Capacity of Prostate Cancer via Slug Inhibition.Ding G, Feng C, Jiang H, Ding Q, Zhang L, Na R, Xu H, Liu J. PLoS One. 2013 Oct 10;8(10):e77400.
Recent MMC/MMCRI GU-Cancer-Related Studies:
Improved Survival Outcomes in Cancer Patients with Hereditary Hemorrhagic Telangiectasia. Duarte CW, Murray K, Lucas FL, Fairfield K, Miller H, Brooks PC, Vary CP. Cancer Epidemiol Biomarkers Prev. 2013 Nov 5. [Epub ahead of print].
Endoglin-Mediated Suppression of Prostate Cancer Invasion Is Regulated by Activin and Bone Morphogenetic Protein Type II Receptors.Breen MJ, Moran DM, Liu W, Huang X, Vary CP, Bergan RC.PLoS One. 2013;8(8):e72407. doi: 10.1371/journal.pone.0072407.
The value of personalised risk information: a qualitative study of the perceptions of patients with prostate cancer.Han PK, Hootsmans N, Neilson M, Roy B, Kungel T, Gutheil C, Diefenbach M, Hansen M.BMJ Open. 2013 Sep 13;3(9):e003226. doi: 10.1136/bmjopen-2013-003226.
National evidence on the use of shared decision making in prostate-specific antigen screening.Han PK, Kobrin S, Breen N, Joseph DA, Li J, Frosch DL, Klabunde CN. Ann Fam Med. 2013 Jul-Aug;11(4):306-14. doi: 10.1370/afm.1539.